Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 4, 2006, Pages

  Levy, Ryan M ^a   Prince, Jose M ^a   Yang, Runkuan ^b   Mollen, Kevin P ^a   Liao, Hong ^a   Watson, Gregory A ^a   Fink, Mitchell P ^a,b   Vodovotz, Yoram ^a   Billiar, Timothy R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD14; Innate immunity; Liver injury; Trauma

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; FEMUR FRACTURE; HEPATITIS; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LIVER CELL DAMAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

ALANINE TRANSAMINASE; ANIMALS; FEMORAL FRACTURES; HEPATITIS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749329020     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00793.2005     Document Type: Article

References (64)

1. Ayala A, Perrin MM, Meldrum DR, Ertel W, and Chaudry IW. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2: 170-174, 1990.
2. Barsness, KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, and McIntyre RC. Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287: R592-R599, 2004.
3. Beutler B, Hoebe K, Du X, and Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 74: 479-485, 2003.
4. Biffl WL, Moore EE, Moore FA, and Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224: 647-664, 1996.
5. Boldt J, Wollbruck M, Kuhn D, Linke LC, and Hempelmann G. Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 107: 787-792, 1995.
6. Cinat ME, Waxman K, Granger GA, Pearce W, Annas C, and Daughters K. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg 179: 529-537, 1994.
7. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216: 117-134, 1992.
8. DeMaria EJ, Pellicane JV, and Lee RB. Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma 35: 720-724, 1993.
9. Endo S, Inada K, Yamada Y, Takakuwa T, Kasai T, Nakae H, Yoshida M, and Ceska M. Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22: 949-955, 1994.
10. Faist E, Baue AE, Dittmer H, and Heberer G. Multiple organ failure in polytrauma patients. J Trauma 23: 775-787 1983.
11. Guo W, Ding J, Huang Q, Jerrells T, and Deitch EA. Alterations in intestinal bacterial flora modulate the systemic cytokine response to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 269: G827-G832, 1995.
12. Hauser CJ, Zhou X, Joshi P, Cuchens MA, Kregor P, Devidas M, Kennedy RJ, Poole GV, and Hughes JL. The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma 42: 895-903, 1997.
13. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, and Goyert SM. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414, 1996.
14. Heinrich PC, Castell JV, and Andus T. Interleukin-6 and the acute phase response. Biochem J 265: 621-636, 1990.
15. Hensler T, Sauerland S, Bouillon B, Raum M, Rixen D, Helling HJ, Andermahr J, and Neugebauer EA. Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma 52: 962-970, 2002.
16. Herman CM, Kraft AR, Smith KR, Artnak EJ, Chisholm FC, Dickson LG, McKee AE Jr, Homer LD, and Levin J. The relationship of circulating endogenous endotoxin to hemorrhagic shock in the baboon. Ann Surg 179: 910-916, 1974.
17. Hierholzer TR and Billiar C. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 286: 302-308, 2001.
18. Hierholzer C and Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 386: 302-308, 2001.
19. Ingalls RR, Heine H, Lien E, Yoshimura A, and Golenbock D. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am 13: 341-353, 1999.
20. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, and Noble PW. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173-1179, 2005.
21. Jiang J, Bahrami S, Leichtfried G, Redl H, Ohlinger W, and Schlag G. Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 221: 100-106, 1995.
22. Johnson GB, Brunn GJ, and Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol 172: 20-24, 2004.
23. Keel M and Trentz O. Pathophysiology of polytrauma. Injury 36: 691-709, 2005.
24. Kim JY, Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, and Abraham E. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288: L958-L965, 2005.
25. Kitchens RL. Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 74: 61-82, 2000.
26. Law MM, Cryer HG, and Abraham E. Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients. J Trauma 37: 100-109, 1994.
27. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, and Beg AA. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166: 7128-7135, 2001.
28. Malone DL, Kuhls D, Napolitano LM, McCarter R, and Scalea T. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma 51: 458-463, 2001.
29. Martin C, Boisson C, Haccoun M, Thomachot L, and Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 25: 1813-1819, 1997.
30. Matzinger P. The danger model: a renewed sense of self. Science 296: 301-305, 2002.
31. Medzhitov R, Preston-Hurlburt P, and Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397, 1997.
32. Meng ZH, Dyer KF, Billiar DJ, and Tweardy TR. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280: C343-C351, 2001.
33. Meng X, Ao L, Song Y, Raeburn CD, Fullerton DA, and Harken AH. Signaling for myocardial depression in hemorrhagic shock: roles of Toll-like receptor 4 and the p55 TNF-α receptor. Am J Physiol Regul Integr Comp Physiol 288: R600-R606, 2005.
34. Moody FG, . Biliary and gut function following shock. J Trauma 30: S179-S184, 1990.
35. Moore EE. Synergy of bone fractures, soft tissue disruption, and hemorrhagic shock in the genesis of postinjury immunochaos: the pathway to multiple organ failure. Crit Care Med 26: 1305-1306, 1998.
36. Napolitano LM, Ferrer T, McCarter RJ Jr, and Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 49: 647-652, 2000.
37. Napolitano LM, Koruda MJ, Meyer AA, and Baker CC. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 5: 202-207, 1996.
38. Nathan C. Points of control in inflammation. Nature 420: 846-852, 2002.
39. Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, and Ertel W. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42: 863-870, 1997.
40. Ohashi K, Burkart V, Flohe S, and Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164: 558-561, 2000.
41. Okamura, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, and Strauss JF 3rd. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276: 10229-10233, 2001.
42. Oyama J Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, and Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789, 2004.
43. Partrick DA, Moore FA, Moore EE, Biffl WL, Sauaia A, and Barnett CC Jr. Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. Am J Surg 172: 425-429, 1996.
44. Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AO, and Simmons RL. Hemorrhagic shock. Curr Probl Surg 32: 925-1002, 1995.
45. Peitzman AB, Udekwu AO, Ochoa J, and Smith S. Bacterial translocation in trauma patients. J Trauma 31: 1083-1086, 1991.
46. Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, and Billiar TR. Toll-like receptor-4 (TLR4) signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202: 407-417, 2006.
47. Rose S and Marzi I. Mediators in polytrauma - pathophysiological significance and clinical relevance. Langenbecks Arch Surg 383: 199-208, 1998.
48. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, van der Meer JW, and Goris RJ. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218: 769-776, 1993.
49. Roumen RM, Hendriks T, Wevers RA, and Goris JA. Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 128: 453-457, 1993.
50. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, Malle E, Schaefer RM, and Grone HJ. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115: 2223-2233, 2005.
51. Schirmer WJ, Schirmer JM, Townsend MC, and Fry DE. Femur fracture with associated soft-tissue injury produces hepatic ischemia. Possible cause of hepatic dysfunction. Arch Surg 123: 412-415, 1988.
52. Scott MJ, Liu S, Su GL, Vodovotz Y, and Billiar TR. Hepatocytes enhance effects of lipopolysaccharide on liver nonparenchymal cells through close cell interactions. Shock 23: 453-458, 2005.
53. Sherry RM, Cue JI, Goddard JK, Parramore JB, and DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 40: 613-616, 1996.
54. Strecker W, Gebhard F, Rager J, Bruckner UB, Steinbach G, and Kinzl L. Early biochemical characterization of soft-tissue trauma and fracture trauma. J Trauma 47: 358-364, 1999.
55. Su GL, Goyert SM, Fan MH, Aminlari A, Gong KQ, Klein RD, Myc A, Alarcon WH, Steinstraesser L, Remick DG, and Wang SC. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Am J Physiol Gastrointest Liver Physiol 283: G640-G645, 2002.
56. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, and Simon JC. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111, 2002.
57. Toth B, Yokoyama Y, Schwacha MG, George RL, Rue LW 3rd, Bland KI, and Chaudry IH. Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol 97: 2184-2189, 2004.
58. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, and Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143, 2005.
59. Wattanasirichaigoon S, Menconi MJ, Delude RL, and Fink MP. Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12: 127-133, 1999.
60. Wichmann MW, Ayala A, and Chaudry IH. Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 26: 1372-1378, 1998.
61. Wright SD, Ramos RA, Tobias PS, Ulevitch JC, and Mathison RJ. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433, 1990.
62. Yang XP, Schaper F, Teubner A, Lammert F, Heinrich PC, Matern S, and Siewert E. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J Hepatol 43: 704-710, 2005.
63. Yao YM, Redl H, Bahrami S, and Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res 47: 201-210, 1998.
64. Zellweger R, Ayala A, DeMaso CM, and Chaudry IH. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 4: 149-153, 1995.